SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-16-569866
Filing Date
2016-04-29
Accepted
2016-04-29 17:02:07
Documents
4
Period of Report
2016-06-16
Effectiveness Date
2016-04-29

Document Format Files

Seq Description Document Type Size
1 DEF 14A d187280ddef14a.htm DEF 14A 337639
2 GRAPHIC g187280g07h34.jpg GRAPHIC 40546
3 GRAPHIC g187280g59d66.jpg GRAPHIC 26624
4 GRAPHIC g187280p46.jpg GRAPHIC 6946
  Complete submission text file 0001193125-16-569866.txt   441305
Mailing Address 7327 OAK RIDGE HWY SUITE B KNOXVILLE TN 37931
Business Address 7327 OAK RIDGE HWY SUITE B KNOXVILLE TN 37931 865-769-4011
PROVECTUS BIOPHARMACEUTICALS, INC. (Filer) CIK: 0000315545 (see all company filings)

IRS No.: 900031917 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-36457 | Film No.: 161607927
SIC: 2834 Pharmaceutical Preparations